Eric Weisblum - 28 Apr 2020 Form 4/A - Amendment Insider Report for Silo Pharma, Inc. (SILO)

Role
CEO, CFO and President, Director
Signature
/s/ Eric Weisblum
Issuer symbol
SILO
Transactions as of
28 Apr 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
17 May 2021, 07:33:20 UTC
Date Of Original Report
30 Apr 2020
Previous filing
17 May 2021
Next filing
15 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILO Common Stock Award +7,630,949 +13131% 7,689,063 28 Apr 2020 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued to the Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, by and between the Issuer and the Reporting Person.
F2 This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on April 30, 2020, which erroneously included the Reporting Person's stock options in Column 5 of Table I.